Status: current, Primitive. Date: 30-Apr 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2317351000168113 | hylan G-F 20 (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2317361000168110 | hylan G-F 20 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| hylan G-F 20 | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| hylan G-F 20 | has intended active ingredient | True | hylan G-F 20 | Inferred relationship | Some | 1 |
| hylan G-F 20 8 mg / 1 mL injection, 6 mL syringe (medicinal product unit of use) | has intended active ingredient | True | hylan G-F 20 | Inferred relationship | Some | 1497316836 |
| hylan G-F 20 8 mg / 1 mL injection, 6 mL syringe (medicinal product unit of use) | has Australian BoSS | True | hylan G-F 20 | Inferred relationship | Some | 1497316836 |
| Synvisc-One 8 mg/mL injection, 6 mL syringe | has Australian BoSS | True | hylan G-F 20 | Inferred relationship | Some | 36063236 |
| Synvisc-One 8 mg/mL injection, 6 mL syringe | has intended active ingredient | True | hylan G-F 20 | Inferred relationship | Some | 36063236 |
This concept is not in any reference sets
FHIR